Abstract
Ecarin is a venom from the saw-scaled viper, Echis carinatus, which catalyzes prothrombin into meizothrombin. This venom is used in several hemostasis laboratory assays, including ecarin clotting time (ECT) and ecarin chromogenic assays (ECA). The use of these ecarin-based assays was first implemented as a tool for monitoring the infusion of a direct thrombin inhibitor, hirudin. Subsequently, this method has been more recently employed for measuring either the pharmacodynamic or pharmacokinetic properties of the oral direct thrombin inhibitor, dabigatran. In this chapter, the procedure for performing manual ECT and automated and manual ECA for measuring thrombin inhibitors is described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- APTT:
-
Activated partial thromboplastin time
- DTI:
-
Direct thrombin inhibitors
- ECA:
-
Ecarin chromogenic assay
- ECT:
-
Ecarin clotting time
- EU:
-
Ecarin units
- PD:
-
Pharmacodynamics
- PK:
-
Pharmacokinetics
- PPP:
-
Platelet-poor plasma
- QC:
-
Quality control
References
Gosselin RC, Douxfils J (2020) Ecarin based coagulation testing. Am J Hematol 95(7):863–869
Nowak G, Bucha E (1996) Quantitative determination of hirudin in blood and body fluids. Semin Thromb Haemost 22:197–202
Hawes EM, Deal AM, Funk-Adcock D, Gosselin R, Jeanneret C, Cook AM, Taylor JM, Whinna HC, Winkler AM, Moll S (2013) Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels. J Thromb Haemost 11(8):1493–1502
Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G (1997) Monitoring of recombinant hirudin: assessment of a plasma-based Ecarin clotting time assay. Thromb Res 86:373–383
van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A (2010) Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103(6):1116–1127
Lange U, Nowak G, Bucha E (2003) Ecarin chromogenic assay – a new method for quantitative determination of direct thrombin inhibitors like hirudin. Pathophysiol Haemost Thromb 33(4):184–191
Nowak G, Lange U, Bucha E (2008) Drug monitoring of argatroban using the ecarin chromogenic assay. Sem Thromb Hemost 34(Suppl 1):81–86
Gosselin RC, Dwyre DM, Dager WE (2013) Measuring dabigatran concentrations using a chromogenic ecarin clotting time assay. Ann Pharmacother 47(12):1635–1640
Clinical and Laboratory Standards Institute (CLSI) (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assay and molecular hemostasis assays; approved guideline. CLSI document H21-A5. Clinical and Laboratory Standards Institute, Wayne
Douxfils J, Adcock DM, Bates SM, Favaloro EJ, Gouin-Thibault I, Guillermo C, Kawai Y, Lindhoff-Last E, Kitchen S, Gosselin RC (2021) Update of the international council for standardization in haematology recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost 121(8):1008–1020
Ecarin and instructions for Ecarin Clotting Time. Product code 116-01. Data sheets 5401 & 5301. Pentapharm Ltd., Basel
STA- ECA II Instructions for Use. Ref 01108 (2015) Diagnostica Stago, Asnières sur Seine
STA Dabigatran Calibrator Instructions for Use Ref 01109 (2015) Diagnostica Stago, Asnières sur Seine
STA Dabigatran Control Instructions for Use Ref 01110 (2015) Diagnostica Stago, Asnières sur Seine
Conflict of Interest
RCG receives consulting fees from Sysmex America Inc.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gosselin, R.C. (2023). Ecarin-Based Methods for Measuring Thrombin Inhibitors. In: Favaloro, E.J., Gosselin, R.C. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 2663. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3175-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3175-1_23
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3174-4
Online ISBN: 978-1-0716-3175-1
eBook Packages: Springer Protocols